• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物在荷兰智障(ID)个体中的使用:处方的流行率和原因。

Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription.

机构信息

Vanboeijen, Centre for the Intellectually Disabled, Assen, The Netherlands.

出版信息

J Intellect Disabil Res. 2010 Jul;54(7):659-67. doi: 10.1111/j.1365-2788.2010.01275.x. Epub 2010 Apr 20.

DOI:10.1111/j.1365-2788.2010.01275.x
PMID:20426795
Abstract

BACKGROUND

We investigated antipsychotic drug prescription practice of Dutch ID physicians, studying prevalence of antipsychotic drug use, reasons for prescription and the relationship between these reasons and patient characteristics.

METHODS

A cross-sectional study of medical and pharmaceutical records in a population living in residential settings of three care providers for persons with IDs in the Netherlands (n = 2373).

RESULTS

Prevalence of antipsychotic drug use was 32.2% (95% CI 30.1-33.9). Behavioural problems were the reason for prescription of antipsychotic drugs in 58% of cases and psychotic disorder or psychotic symptoms in 22.5%. In 11.7% the diagnosis of psychotic disorder was specified according to DSM-IV criteria. In 18.5% the reason for prescription was not noted in the medical record. Behavioural problems as reason for prescription was associated with profound and severe ID, living in a central location and male sex. Psychotic disorder specified according to DSM-IV as indication for prescription was negatively associated with profound and severe ID and with presence of an additional mental disorder. Absence of a noted reason for prescription was associated with female sex and with the presence of an additional mental disorder.

DISCUSSION

Current prevalence and reason for prescription of antipsychotic drugs are similar with outcomes of previous studies. Our results show the continuing lack of evidence-based psychopharmacological treatment in mental health care for persons with IDs.

摘要

背景

我们研究了荷兰 ID 医生的抗精神病药物处方实践,研究了抗精神病药物的使用情况、处方的原因以及这些原因与患者特征之间的关系。

方法

这是一项在荷兰三家 ID 患者居住机构的护理提供者中进行的横断面研究,对医疗和药物记录进行了调查(n = 2373)。

结果

抗精神病药物使用率为 32.2%(95%CI 30.1-33.9)。行为问题是 58%的患者使用抗精神病药物的原因,而精神障碍或精神症状则占 22.5%。11.7%的患者按照 DSM-IV 标准明确诊断为精神障碍。18.5%的病历中未记录处方的原因。将行为问题作为处方的原因与严重的智力障碍、居住在中心位置和男性性别有关。根据 DSM-IV 规定将精神障碍明确为处方的指征与严重的智力障碍和存在其他精神障碍有关。未记录处方的原因与女性性别和存在其他精神障碍有关。

讨论

目前抗精神病药物的使用情况和使用原因与以往研究的结果相似。我们的研究结果表明,在 ID 患者的精神卫生保健中,仍然缺乏基于证据的精神药理学治疗。

相似文献

1
Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription.抗精神病药物在荷兰智障(ID)个体中的使用:处方的流行率和原因。
J Intellect Disabil Res. 2010 Jul;54(7):659-67. doi: 10.1111/j.1365-2788.2010.01275.x. Epub 2010 Apr 20.
2
Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.医生不愿停止为智障人士长期使用的非标签抗精神病药物的原因。
J Intellect Disabil Res. 2017 Oct;61(10):899-908. doi: 10.1111/jir.12385. Epub 2017 May 30.
3
Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?精神发育迟滞患者攻击行为的药物治疗:治疗还是虐待?
J Intellect Disabil Res. 2010 Jan 1;54(1):1-16. doi: 10.1111/j.1365-2788.2009.01232.x. Epub 2009 Dec 8.
4
Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities.对1539名成年智障者进行筛查时发现的眼部诊断患病率。
Ophthalmology. 2004 Aug;111(8):1457-63. doi: 10.1016/j.ophtha.2003.12.051.
5
Prevalence of visual impairment in adults with intellectual disabilities in the Netherlands: cross-sectional study.荷兰成年智障者视力损害患病率:横断面研究
Eye (Lond). 2006 Sep;20(9):1004-10. doi: 10.1038/sj.eye.6702059. Epub 2005 Sep 9.
6
Prevalence of hypertension in adults with intellectual disability in the Netherlands.荷兰智力残疾成年人中的高血压患病率。
J Intellect Disabil Res. 2009 Jan;53(1):78-84. doi: 10.1111/j.1365-2788.2008.01130.x. Epub 2008 Nov 6.
7
Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.意大利普通人群中抗精神病药物处方的患病率、发病率和持续性:1999 - 2002年回顾性数据库分析
Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):412-20. doi: 10.1002/pds.1162.
8
[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].[法国13家精神病医院抗精神病药物的处方模式]
Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7.
9
A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.针对轻度智力残疾和精神疾病住院患者的非适应证用药调查。
J Intellect Disabil Res. 2005 Nov;49(Pt 11):858-64. doi: 10.1111/j.1365-2788.2005.00723.x.
10
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.儿童和青少年使用抗精神病药物进行门诊治疗的全国趋势。
Arch Gen Psychiatry. 2006 Jun;63(6):679-85. doi: 10.1001/archpsyc.63.6.679.

引用本文的文献

1
Developing and testing of an assessment tool for appropriate psychotropic drug prescribing in people with intellectual disabilities.开发和测试一种用于智障人士合理开具精神药物处方的评估工具。
Ther Adv Drug Saf. 2025 Jul 8;16:20420986251342351. doi: 10.1177/20420986251342351. eCollection 2025.
2
Development of practice-guided measures to improve guideline adherence in psychotropic medication for adults with intellectual disabilities.制定实践指导措施以提高智障成年人精神药物治疗指南的依从性。
Int J Dev Disabil. 2023 Dec 4;71(4):638-642. doi: 10.1080/20473869.2023.2272091. eCollection 2025.
3
Exploring Connections Between Living Situations and Antipsychotic Prescribing Practices for People With Intellectual Disabilities.
探索智障人士生活状况与抗精神病药物处方实践之间的联系。
Psychiatr Res Clin Pract. 2024 Oct 11;7(1):25-31. doi: 10.1176/appi.prcp.20240050. eCollection 2025 Spring.
4
Transmural collaborative care model for cardiovascular risk management and medication review in patients using antipsychotics in primary care (TACTIC): A study protocol of an incomplete stepped wedge cluster randomized trial.基层医疗中使用抗精神病药物患者心血管风险管理与用药评估的跨壁协作护理模式(TACTIC):一项不完全阶梯楔形整群随机试验的研究方案
Contemp Clin Trials Commun. 2025 Jan 9;44:101418. doi: 10.1016/j.conctc.2024.101418. eCollection 2025 Apr.
5
Prescriptions for Antipsychotics: Youth with Intellectual/Developmental Disabilities Compared to Youth without Intellectual/Developmental Disabilities.抗精神病药物处方:有智力/发育障碍的青少年与无智力/发育障碍的青少年对比
J Autism Dev Disord. 2024 Apr 28. doi: 10.1007/s10803-024-06344-z.
6
Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour.使智力残疾和具有挑战行为的成年人的生活质量与非标签使用精神药物指南保持一致。
Int J Dev Disabil. 2023 May 17;69(3):398-413. doi: 10.1080/20473869.2023.2195721. eCollection 2023.
7
Mental healthcare for adults with mild intellectual disabilities: population-based database study in Dutch mental health services.针对轻度智力障碍成年人的心理保健:荷兰心理健康服务机构基于人群的数据库研究
BJPsych Open. 2023 Mar 3;9(2):e48. doi: 10.1192/bjo.2023.31.
8
Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers.抗精神病药撤药治疗智力障碍成人行为问题:处方者的经验和观点。
Int J Environ Res Public Health. 2022 Dec 19;19(24):17095. doi: 10.3390/ijerph192417095.
9
Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience.《为有智力障碍的成年人的挑战性行为撤掉抗精神病药物:专家经验的体验与观点》
Int J Environ Res Public Health. 2022 Nov 24;19(23):15637. doi: 10.3390/ijerph192315637.
10
Management of psychotropic medications in adults with intellectual disability: a scoping review.成人智力残疾者精神药物管理:范围综述。
Ann Med. 2022 Dec;54(1):2486-2499. doi: 10.1080/07853890.2022.2121853.